Hey all, welcome back to the Real Life Pharmacology podcast. Thank you so much for listening today.

Definitely go check out Real Life Pharmacology.com. Get your free 30-plus page PDF on the top 200 drugs.

Great little study guide, just refresher for clinical practice pearls, as well as I put on

there things that commonly come up on board exams. So I really wanted to provide that resource

for you guys, especially those of you that might be doing a little brushing up, a little studying

on pharmacology. So go subscribe. We'll get you

updates as well when we've got new podcasts and content available as well. So again,

real-life pharmacology.com. All right, so let's get into the drug of the day today, and we are

going to talk about palivismab.

Brand name of this medication is synergis, and this medication is really specific to pediatrics.

It's not a topic.

I talk about a ton because there's so much complicated things that happen in the adult

and geriatric space. But I did have a request to take a peek at this medication and run down some

details. So knowing that, you know, it's not typically used in adults and geriatrics, what do we use

this for? So this medication is actually used in the prevention of respiratory-sensidial virus.

Okay? And that's more commonly, I think, talked about are known as RSV, because it's easier to say as well.

RSV is a respiratory infection, obviously respiratory syncedial virus, caused by a virus, obviously.

And most older age adult patients have zero issues with RSV,

and really symptoms are like the common cold.

But younger patients, particularly under the age of one or two,

can potentially struggle with RSV to a much greater extent to the extent that they

have difficulty with breathing and things of that nature. And particularly patients who have really

...